Increased risk of stroke among patients with Crohn's disease: a population-based matched cohort study

Joseph Jordan Keller1, Jui Wang, Ya-Li Hwang

  • 1School of Public Health, College of Public Health and Nutrition, Taipei Medical University, Taipei, Taiwan.

Insights

Patients with Crohn's disease (CD) have a nearly double risk of subsequent stroke. This risk is higher in women and older adults, highlighting a critical link between IBD and cerebrovascular events.

Area of Science:

  • Gastroenterology and Neurology
  • Epidemiology and Public Health

Background:

  • Crohn's disease (CD), a type of inflammatory bowel disease (IBD), may share prognostic factors with stroke development.
  • Existing literature presents controversial findings on the association between CD and stroke.
  • This study investigates the risk of subsequent stroke in CD patients within an Asian population.

Purpose of the Study:

  • To estimate the risk of subsequent stroke in individuals diagnosed with Crohn's disease.
  • To compare stroke incidence in CD patients versus a matched cohort without IBD.
  • To analyze stroke risk stratification by age and gender in CD patients.

Main Methods:

  • A historical cohort study utilizing the Taiwan National Health Insurance Database.
  • Inclusion of 3309 CD patients and 13,236 matched comparison subjects without IBD.
  • Application of Cox proportional hazards regressions, with adjustments for comorbidities and pharmaceuticals, and stratified analyses by age and gender.

Main Results:

  • Adjusted hazard ratio (HR) for subsequent stroke in CD patients was 1.911 (95% CI: 1.65-2.22) compared to controls.
  • Increased stroke risk was observed in CD patients aged 40-50 (HR=2.29) and over 50 (HR=1.88), but not in the 30-40 age group.
  • Women with CD exhibited a higher risk of stroke (HR=2.39) than men (HR=1.50).

Conclusions:

  • This population-based cohort study confirms an elevated risk of subsequent stroke among patients with Crohn's disease in Taiwan.
  • The findings underscore a significant association between IBD and cerebrovascular disease, particularly in specific demographic groups.
  • Further research into the underlying mechanisms and preventative strategies for stroke in CD patients is warranted.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
2
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
738
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
686
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.6K